PolyArginine Treated vEiN grafTs (PATENT)
Phase of Trial: Phase I/II
Latest Information Update: 23 Sep 2016
At a glance
- Drugs LT 1951 (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms PATENT
- 07 Sep 2016 Status changed from active, no longer recruiting to discontinued.
- 17 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 24 Nov 2005 New trial record.